Question:  Thomas R. Frieden, M.D. was the acting administrator of a federal public health agency that was ormally organized in what year?

Context articles: Global Public Health Intelligence Network
Agency for Toxic Substances and Disease Registry
Anne Schuchat
Don I. Wortman
Federal Health Agency
Public Health Agency of Sweden
State health agency
Public Health Agency of Canada
Tom Frieden
Mapp Biopharmaceutical

The Global Public Health Intelligence Network (GPHIN) is an electronic public health early warning system developed by Canada's Public Health Agency, and is part of the World Health Organization's (WHO) Global Outbreak Alert and Response Network (GOARN).
 This system monitors internet media, such as news wires and websites, in nine languages in order to help detect and report potential disease outbreaks or other health threats around the world.
The Agency for Toxic Substances and Disease Registry (ATSDR) is a federal public health agency within the United States Department of Health and Human Services.
 The agency focuses on minimizing human health risks associated with exposure to hazardous substances.
 It works closely with other federal, state, and local agencies; tribal governments; local communities; and healthcare providers.
 Its mission is to "Serve the public through responsive public health actions to promote healthy and safe environments and prevent harmful exposures."
 ATSDR was created as an advisory, nonregulatory agency by the Superfund legislation and was formally organized in 1985.
Anne Schuchat is a U.S. medical doctor who served as the Acting Director of the Centers for Disease Control and Prevention (CDC) and Acting Administrator of the Agency for Toxic Substances and Disease Registry (ATSDR) until July 7, 2017.
 She became Acting Director of CDC and Acting Administrator of ATSDR on January 20, 2017.
 She is an Assistant Surgeon General holding the ranks of rear admiral in the United States Public Health Service Commissioned Corps.
 Having worked with the CDC on immunization, respiratory, and other infectious diseases since 1988, she served as the Interim Deputy Director for Science and Public Health at the CDC from February 2009 to June 2009.
 She has also held other posts in the CDC.
Don I. Wortman is a retired U.S. federal government administrator who served 27 years in senior-level executive positions in many federal government agencies.
 He was Acting Commissioner of the Social Security Administration (SSA) from December 13, 1977 to October 4, 1978.
 In early 1977, while working at the Department of Health, Education and Welfare (HEW)—precursor to the Department of Health and Human Services—he was Chairman of the task force for implementing the reorganization of HEW.
 This reorganization included the merging of the Medicare and Medicaid programs into a new agency; this agency was named the Health Care Financing Administration (and renamed the Centers for Medicare and Medicaid Services in June 2001).
 He became the first Administrator of the Health Care Financing Administration.
 On two occasions—6 months in 1975 and the first 3 months of 1977—he was Acting Administrator of the Social and Rehabilitation Services, the agency which, at that time, administered the Medicaid program and the Aid to Families with Dependent Children program.
The Federal Health Agency (German: "Bundesgesundheitsamt" ) was a federal government agency and the central research institution for public health in Germany.
 It was founded in 1876, named the Imperial Health Agency (German: "Kaiserliches Gesundheitsamt" ).
 It was succeeded by the Reichsgesundheitsamt in 1918 and by the Bundesgesundheitsamt in 1952 (both meaning Federal Health Agency).
 The agency was dissolved in 1994, and its responsibilities transferred to three institutions, the Federal Institute for Drugs and Medical Devices, the Robert Koch Institute and the Federal Institute for Health Consumer Protection and Veterinary Medicine.
The Public Health Agency of Sweden (Swedish: "Folkhälsomyndigheten" ) is a Swedish government agency with national responsibility for public health.
 It falls under the Ministry of Health and Social Affairs and works to promote public health and to prevent illness and injuries through education.
 It monitors the health of the population, infectious disease control measures, and public health interventions, and assists the Government in its decision-making process by providing facts and knowledge.
 The agency is tasked with minimizing negative environmental impact on human health, and participates in the work of the EU and international public health organisations, such as the WHO and IANPHI.
A state health agency (SHA), or state department of health, is a department or agency of the state governments of the United States focused on public health.
 The state secretary of health is a constitutional or at times a statutory official in several states of the United States.
 The position is the chief executive official for the state's state health agency (or equivalent), chief administrative officer for the state's Board of Health (or equivalent), or both.
The Public Health Agency of Canada ("French: Agence de la santé publique du Canada") is an agency of the Government of Canada that is responsible for public health, emergency preparedness, and response and infectious and chronic disease control and prevention.
 It was formed by Order in Council in 2004 and subsequently by legislation that came into force December 15, 2006 and it is member of the Federal Health Portfolio (along with Health Canada, the Canadian Institute of Health Research, and other organizations).
Thomas R. Frieden, M.D., M.P.H is an American infectious disease expert and the former director of the U.S. Centers for Disease Control and Prevention (CDC) and acting administrator of the Agency for Toxic Substances and Disease Registry from 2009 to 2017.
 He was appointed by President Barack Obama.
 He previously served as commissioner of the New York City Department of Health and Mental Hygiene (DOHMH) from 2002 to 2009.
Mapp Biopharmaceutical is an American pharmaceutical company based in San Diego, California.
 It is responsible for the research and development of ZMapp, a drug which is still under development, comprising three humanized monoclonal antibodies as a treatment for Ebola virus disease.
 The drug was first tested in humans during the 2014 West Africa Ebola virus outbreak.
 The ZMapp drug is a result of the collaboration between Mapp Biopharmaceutical, LeafBio (the commercial arm of Mapp Biopharmaceutical), Defyrus Inc. (Toronto), the U.S. government and the Public Health Agency of Canada.
 The antibody work came out of research projects funded by Defense Advanced Research Projects Agency (DARPA) more than a decade ago, and years of funding by the Public Health Agency of Canada.
 ZMapp is manufactured in the tobacco plant "Nicotiana benthamiana" in the bioproduction process known as "pharming" by Kentucky BioProcessing, a subsidiary of Reynolds American.